Mannkind (MNKD) Inventory (2014 - 2026)
Mannkind (MNKD) posted quarterly Inventory of $49.2 million for Q1 2026, up 70.17% year-over-year from $28.9 million in Q1 2025, and up 39.23% quarter-over-quarter from $35.3 million in Q4 2025.
Mannkind (MNKD) Inventory (2014 - 2026) Analysis & Trends
Mannkind (MNKD) has reported Inventory for 13 consecutive years, with $49.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory rose 70.17% year-over-year to $49.2 million; the TTM figure through Mar 2026 stood at $49.2 million (up 70.17% YoY), while the FY2025 annual figure was $35.3 million, up 26.63% from the prior year.
- Inventory rose to $49.2 million in Q1 2026 per MNKD's latest filing, from $35.3 million in the prior quarter.
- Across five years, Inventory topped out at $49.2 million in Q1 2026 and bottomed at $8.0 million in Q1 2022.
- Historically, Inventory has averaged $26.2 million across 5 years, with a median of $26.7 million in 2024.
- Annual changes were most pronounced in 2022 — Inventory jumped 204.42% — and 2024, when it dropped 2.31%.
- Mannkind's Inventory stood at $21.8 million in 2022, then jumped by 31.11% to $28.5 million in 2023, then retreated by 2.31% to $27.9 million in 2024, then gained by 26.63% to $35.3 million in 2025, then soared by 39.23% to $49.2 million in 2026.
- Business Quant data shows MNKD's Inventory at $49.2 million in Q1 2026, $35.3 million in Q4 2025, and $27.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Mannkind | 1.19 Bn | 1.08 Bn | 94.97 Mn | 44.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 44.42 Mn |
| Mar 31, 2026 | 49.17 Mn |
| Dec 31, 2025 | 35.31 Mn |
| Sep 30, 2025 | 26.97 Mn |
| Jun 30, 2025 | 28.49 Mn |
| Mar 31, 2025 | 28.89 Mn |
| Dec 31, 2024 | 27.89 Mn |
| Sep 30, 2024 | 26.66 Mn |
| Jun 30, 2024 | 24.75 Mn |
| Mar 31, 2024 | 26.44 Mn |
| Dec 31, 2023 | 28.55 Mn |
| Sep 30, 2023 | 27.12 Mn |
| Jun 30, 2023 | 25.29 Mn |
| Mar 31, 2023 | 22.00 Mn |
| Dec 31, 2022 | 21.77 Mn |
| Sep 30, 2022 | 18.27 Mn |
| Jun 30, 2022 | 20.57 Mn |
| Mar 31, 2022 | 8.04 Mn |
| Dec 31, 2021 | 7.15 Mn |
| Sep 30, 2021 | 7.48 Mn |